Stay updated on Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page.

Latest updates to the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page’s revision/version footer was updated from v3.5.2 to v3.5.3, indicating a software release change rather than a modification to the clinical trial information.SummaryDifference0.0%

- Check22 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedAdded glossary term: Hereditary factor VIII deficiency disease. Removed glossary term: Hemophilia A.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check57 days agoChange DetectedAdded a publication reference (Msihid J et al.) under Publications From PubMed for XTEND-1. The reference summarizes Haemophilia QoL data from XTEND-1.SummaryDifference0.0%

- Check86 days agoChange DetectedSite revision updated from v3.4.1 to v3.4.2. This is a minor system update and does not affect study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of Efanesoctocog Alfa in Severe Hemophilia A Clinical Trial page.